The Evolution of the Pharmaceutical Industry Over the Past 50 Years: A Personal Reflection
Henry Grabowski
International Journal of the Economics of Business, 2011, vol. 18, issue 2, 161-176
Abstract:
The pharmaceutical industry has an outstanding record of innovative performance over the past 50 years. The R&D process has become more knowledge-based and a market for innovation has emerged between research start-ups, development-stage firms, and the larger, multinational companies. At the same time, R&D costs have increased several fold over time and generic products now dominate many traditional therapeutic areas. The current challenge for the industry is to discover new therapies for chronic diseases with high unmet needs like Alzheimer's disease and various auto-immune diseases and cancers that afflict an increasingly aging population. Recent advances in molecular biology and related fields provide a scientific foundation to undertake these R&D efforts, although the time path and outcomes remain subject to many risks and uncertainties.
Keywords: Pharmaceuticals; Innovation; R&D; Biotechnology; Generics; Alliances (search for similar items in EconPapers)
Date: 2011
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)
Downloads: (external link)
http://www.tandfonline.com/10.1080/13571516.2011.584421 (text/html)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:taf:ijecbs:v:18:y:2011:i:2:p:161-176
Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CIJB20
DOI: 10.1080/13571516.2011.584421
Access Statistics for this article
International Journal of the Economics of Business is currently edited by Eleanor Morgan
More articles in International Journal of the Economics of Business from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().